The situation of gynecological cancers in Thailand: incidence, histopathology, and survival outcomes from national cancer registry data
Journal of Gynecologic Oncology · 2026
DOI: 10.3802/jgo.2026.37.e56 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gynecologic Oncology, 2026. Verfasst von Supakorn Pitakkarnkul und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecologic Oncology, National Cancer Institute, Bangkok, Thailand. supakorn_dr@hotmail.com. Hauptthemen laut MEDLINE: Genital Neoplasms, Female, Ovarian Neoplasms. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
OBJECTIVE: Cervical, uterine, and ovarian cancers are the 3 main cancers of the female reproductive system. Analyzing data from the cancer registry database will help understand the situation and trends of these diseases. METHODS: This study utilized data from Thailand's population-based cancer registries covering 16 provinces across 5 geographic regions between 2019 and 2021. Data collection included demographic characteristics, cancer incidence, histopathology, disease stage, and survival outcomes. Incidence rates were calculated using age-standardized rates (ASRs) per 100,000 population, and 5-year survival outcomes were compared across 2 time periods (2013-2017 vs. 2018-2022). RESULTS: During 2019-2021, Thailand recorded a mean annual ASR of 132.9 for females, with cervical cancer remaining the most common gynecologic cancer. The incidence of cervical cancer decreased from 19.5 per 100,000 in 1995-2000 to 10.3 per 100,000 in 2019-2021. Uterine cancer demonstrated a rising trend, from 3.6 per 100,000 in 2004-2006 to 6.1 per 100,000 in 2019-2021, while ovarian cancer incidence remained relatively stable at 5.9 per 100,000. Five-year survival rates improved significantly across all gynecologic cancers in 2018-2022 compared with 2013-2017. The hazard ratios for overall survival by stage ranged from 0.57 to 0.81 for cervical, 0.53 to 0.82 for uterine, and 0.57 to 0.81 for ovarian cancers (all p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gynecologic Oncology, National Cancer Institute, Bangkok, Thailand. supakorn_dr@hotmail.com.
- Women's Health Center, MedPark Hospital, Bangkok, Thailand.
- Department of Digital Medical Working Group, National Cancer Institute, Bangkok, Thailand.
- Department of Gynecologic Oncology, National Cancer Institute, Bangkok, Thailand.
ORCID-Profile: Supakorn Pitakkarnkul, Siriwan Tangjitgamol, Ekapob Sangariyavanich, Rangsiya Buasom, Boonyita Pakkaranang, Uraiwan Khomphaiboonkij, Warangkana Kolaka
Zitieren
APA
Pitakkarnkul, S., Tangjitgamol, S., Sangariyavanich, E., Buasom, R., Pakkaranang, B., Khomphaiboonkij, U., & Kolaka, W. (2026). The situation of gynecological cancers in Thailand: incidence, histopathology, and survival outcomes from national cancer registry data. Journal of Gynecologic Oncology. https://doi.org/10.3802/jgo.2026.37.e56
Vancouver
Pitakkarnkul S, Tangjitgamol S, Sangariyavanich E, Buasom R, Pakkaranang B, Khomphaiboonkij U, et al. The situation of gynecological cancers in Thailand: incidence, histopathology, and survival outcomes from national cancer registry data. Journal of Gynecologic Oncology. 2026. doi:10.3802/jgo.2026.37.e56
BibTeX
@article{Pitakkarnkul2026,
author = {Pitakkarnkul, Supakorn and Tangjitgamol, Siriwan and Sangariyavanich, Ekapob and Buasom, Rangsiya and Pakkaranang, Boonyita and Khomphaiboonkij, Uraiwan and Kolaka, Warangkana},
title = {The situation of gynecological cancers in Thailand: incidence, histopathology, and survival outcomes from national cancer registry data},
journal = {Journal of Gynecologic Oncology},
year = {2026},
doi = {10.3802/jgo.2026.37.e56}
}
EUVIMED